Pacira BioSciences, Inc. ($PCRX)
Filing Information
| Accession Number | 0001628280-26-026669 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 23, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
36,177
Total Value
$500,968.96
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Apr 20, 2026 | Exercise/Conversion | 7,714 | $16.45 | $126,895.30 | 113,055 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 20, 2026 | Sale | 7,714 | $25.14 | $193,929.96 | 105,341 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 21, 2026 | Exercise/Conversion | 2,845 | $16.45 | $46,800.25 | 108,186 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 21, 2026 | Sale | 2,845 | $25.01 | $71,153.45 | 105,341 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 22, 2026 | Exercise/Conversion | 1,500 | $16.45 | $24,675.00 | 106,841 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 22, 2026 | Sale | 1,500 | $25.01 | $37,515.00 | 105,341 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Apr 20, 2026 | Exercise/Conversion | 7,714 | $0.00 | $0.00 | 167,286 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Apr 21, 2026 | Exercise/Conversion | 2,845 | $0.00 | $0.00 | 164,441 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Apr 22, 2026 | Exercise/Conversion | 1,500 | $0.00 | $0.00 | 162,941 | Direct | โ | View Details |